|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.89 USD | -2.06% |
|
-4.10% | -2.60% |
| 06:10am | HSBC Adjusts Price Target on Merck & Co. to $120 From $100, Maintains Buy Rating | MT |
| 12-09 | Formycon Secures Additional Commercialization Partnership for Keytruda Biosimilar | DP |
Highlights
Search
12-09 | DP | |
12-08 | RE | |
12-05 | ||
12-04 | DJ | |
12-04 | MT | |
12-04 | DJ | |
12-04 | DJ | |
12-04 | RE | |
12-04 | RE | |
12-04 | RE | |
12-04 | RE | |
12-02 | ||
12-01 | MT | |
12-01 | MT | |
12-01 | RE | |
12-01 | CI | |
11-26 | MT | |
11-25 | RE | |
11-24 | MT | |
11-24 | ||
11-24 | MT | |
11-21 | RE | |
11-21 | CI | |
11-21 | MT | |
11-21 | RE |
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















